Status:
COMPLETED
Modifying Group Therapy for Bipolar Substance Abusers - 1
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Conditions:
Bipolar Disorder
Substance Dependence
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to modify Integrated Group Therapy (IGT), which is has been found successful for patients with bipolar disorder (BD) and substance use disorder(SUD), so that it can be mor...
Detailed Description
IGT is being compared with 12 sessions of Group Drug Counseling (GDC) in a randomized controlled trial, with a sample size of 60 subjects. GDC is the type of treatment one would likely receive in a co...
Eligibility Criteria
Inclusion
- bipolar disorder substance dependence taking a mood stabilizer
Exclusion
- acute psychosis no substance use in past 60 days no prescribing doctor will not be in area for next 15 months lives too far away
Key Trial Info
Start Date :
July 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2005
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00227838
Start Date
July 1 2003
End Date
August 1 2005
Last Update
January 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
McLean Hospital, Dept. of Psychiatry
Belmont, Massachusetts, United States, 02478 9106